First successful CRISPR gene-editing directly in the blood of a live patient
Patrick Doherty was a healthy, active 65-year-old living County Donegal, Ireland when he was diagnosed
geneediting
Dow Jones Futures: Market Rally Rotation Wanes With Amazon Near Buy Point, Tesla, Nio Rebounding; Gene-Editing Stocks Soar
Dow Jones futures edged lower Monday morning, while S&P 500 futures and Nasdaq futures rose
Landmark field trials show potential of gene-editing in crops
Field trials of gene-edited crops show immense potential. Credit: John Innes Centre Field trials investigating